The therapeutic potential of targeting regulated non-apoptotic cell death
K Hadian, BR Stockwell - Nature Reviews Drug Discovery, 2023 - nature.com
Cell death is critical for the development and homeostasis of almost all multicellular
organisms. Moreover, its dysregulation leads to diverse disease states. Historically …
organisms. Moreover, its dysregulation leads to diverse disease states. Historically …
Parkinson's disease
Parkinson's disease is a recognisable clinical syndrome with a range of causes and clinical
presentations. Parkinson's disease represents a fast-growing neurodegenerative condition; …
presentations. Parkinson's disease represents a fast-growing neurodegenerative condition; …
[HTML][HTML] Neuropathology and molecular diagnosis of Synucleinopathies
Synucleinopathies are clinically and pathologically heterogeneous disorders characterized
by pathologic aggregates of α-synuclein in neurons and glia, in the form of Lewy bodies …
by pathologic aggregates of α-synuclein in neurons and glia, in the form of Lewy bodies …
[HTML][HTML] Diversity and complexity of cell death: a historical review
Death is the inevitable fate of all living organisms, whether at the individual or cellular level.
For a long time, cell death was believed to be an undesirable but unavoidable final outcome …
For a long time, cell death was believed to be an undesirable but unavoidable final outcome …
Cellular functions of the protein kinase ATM and their relevance to human disease
The protein kinase ataxia telangiectasia mutated (ATM) is a master regulator of double-
strand DNA break (DSB) signalling and stress responses. For three decades, ATM has been …
strand DNA break (DSB) signalling and stress responses. For three decades, ATM has been …
Poly (ADP-ribose) polymerase inhibition: past, present and future
The process of poly (ADP-ribosyl) ation and the major enzyme that catalyses this reaction,
poly (ADP-ribose) polymerase 1 (PARP1), were discovered more than 50 years ago. Since …
poly (ADP-ribose) polymerase 1 (PARP1), were discovered more than 50 years ago. Since …
Prussian blue nanozyme as a pyroptosis inhibitor alleviates neurodegeneration
X Ma, J Hao, J Wu, Y Li, X Cai, Y Zheng - Advanced Materials, 2022 - Wiley Online Library
Current pharmacological interventions for Parkinson's disease (PD) remain unsatisfactory in
clinical settings. Inflammasome‐mediated pyroptosis represents a potential therapeutic …
clinical settings. Inflammasome‐mediated pyroptosis represents a potential therapeutic …
Structures of α-synuclein filaments from multiple system atrophy
M Schweighauser, Y Shi, A Tarutani, F Kametani… - Nature, 2020 - nature.com
Synucleinopathies, which include multiple system atrophy (MSA), Parkinson's disease,
Parkinson's disease with dementia and dementia with Lewy bodies (DLB), are human …
Parkinson's disease with dementia and dementia with Lewy bodies (DLB), are human …
Oxidative stress and regulated cell death in Parkinson's disease
PA Dionísio, JD Amaral, CMP Rodrigues - Ageing research reviews, 2021 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disease
worldwide. Motor deficits usually associated with PD correlate with dopaminergic axonal …
worldwide. Motor deficits usually associated with PD correlate with dopaminergic axonal …
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Parkinson's disease prevalence is rapidly increasing in an aging global population. With this
increase comes exponentially rising social and economic costs, emphasizing the immediate …
increase comes exponentially rising social and economic costs, emphasizing the immediate …